These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 36879710)
21. Management of temporomandibular joint diseases: a rare case report of coexisting calcium pyrophosphate crystal deposition and synovial chondromatosis. Murahashi M; Ntege EH; Higa M; Maruyama N; Kawano T; Shimizu Y; Nakamura H BMC Oral Health; 2022 Dec; 22(1):662. PubMed ID: 36587200 [TBL] [Abstract][Full Text] [Related]
22. Pseudogout - a rare manifestation of hungry bone syndrome after focused parathyroidectomy. Tai CH; Oh HB; Seet JE; Ngiam KY Ann R Coll Surg Engl; 2018 May; 100(5):e106-e108. PubMed ID: 29607728 [TBL] [Abstract][Full Text] [Related]
23. Treatment and management of pseudogout: insights for the clinician. Macmullan P; McCarthy G Ther Adv Musculoskelet Dis; 2012 Apr; 4(2):121-31. PubMed ID: 22870500 [TBL] [Abstract][Full Text] [Related]
29. [Calcium pyrophosphate arthropathy (pseudogout) of the temporomandibular joint]. Appel T; Bergé S; Conrad R; Süess K Mund Kiefer Gesichtschir; 2001 Jan; 5(1):61-4. PubMed ID: 11272390 [TBL] [Abstract][Full Text] [Related]
30. Gout and coexisting pseudogout in the knee joint. Yoo Y; Seo YJ; Huh M; Yoo JH; Yun KH; Kim SJ Knee Surg Sports Traumatol Arthrosc; 2011 Apr; 19(4):553-5. PubMed ID: 20802996 [TBL] [Abstract][Full Text] [Related]
31. Calcium pyrophosphate dihydrate crystal deposition disease and pseudogout of the acromioclavicular joint: radiographic and pathologic features. Huang GS; Bachmann D; Taylor JA; Marcelis S; Haghighi P; Resnick D J Rheumatol; 1993 Dec; 20(12):2077-82. PubMed ID: 8014936 [TBL] [Abstract][Full Text] [Related]
32. Tophaceous calcium pyrophosphate dihydrate deposition disease of the knee mimicking an aggressive soft tissue tumour. Watura C; Saifuddin A BMJ Case Rep; 2014 Jun; 2014():. PubMed ID: 24916978 [TBL] [Abstract][Full Text] [Related]
33. Synovial chondromatosis of the temporomandibular joint with calcium pyrophosphate dihydrate crystal deposition disease (pseudogout). Matsumura Y; Nomura J; Nakanishi K; Yanase S; Kato H; Tagawa T Dentomaxillofac Radiol; 2012 Dec; 41(8):703-7. PubMed ID: 23166363 [TBL] [Abstract][Full Text] [Related]
34. Inhibitory effect of low density lipoprotein on the inflammation-inducing activity of calcium pyrophosphate dihydrate crystals. Kumagai Y; Watanabe W; Kobayashi A; Sato K; Onuma S; Sakamoto H J Rheumatol; 2001 Dec; 28(12):2674-80. PubMed ID: 11764217 [TBL] [Abstract][Full Text] [Related]
35. A Case of Pseudogout Following Zoledronic Acid Administration. Hill AC; Al Asmar R; Olajide AA; BenHamed N Cureus; 2021 Jun; 13(6):e15627. PubMed ID: 34277244 [TBL] [Abstract][Full Text] [Related]
36. Prevalence and incidence of non-gout crystal arthropathy in southern Sweden. Hameed M; Turkiewicz A; Englund M; Jacobsson L; Kapetanovic MC Arthritis Res Ther; 2019 Dec; 21(1):291. PubMed ID: 31847885 [TBL] [Abstract][Full Text] [Related]
37. [Diagnosis and treatment of calcium pyrophosphate crystal-induced arthropathy]. Announ N; Guerne PA Z Rheumatol; 2007 Nov; 66(7):573-4, 576-8. PubMed ID: 17932681 [TBL] [Abstract][Full Text] [Related]
38. Coexistent Pseudogout and Afzal W; Wali OM; Cervellione KL; Singh BB; Bagheri F Case Rep Rheumatol; 2016; 2016():5495928. PubMed ID: 27803833 [TBL] [Abstract][Full Text] [Related]
39. Calcium pyrophosphate deposition disease: The role of imaging in their detection and in differential diagnosis of crystal arthropathies. Catelli A; Venetucci P; Castaldo A; Loiudice G; Tarulli FR; Carpiniello M; De Angelis M; Corvino A Radiol Case Rep; 2020 Oct; 15(10):1773-1776. PubMed ID: 32774579 [TBL] [Abstract][Full Text] [Related]
40. Calcium pyrophosphate dihydrate deposition disease (CPPD)/Pseudogout of the temporomandibular joint - FNA findings and microanalysis. Naqvi AH; Abraham JL; Kellman RM; Khurana KK Cytojournal; 2008 Apr; 5():8. PubMed ID: 18426573 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]